stockportfolio.pro
Stocks / RMD vs UTHR
RMD vs UTHR
ResMed Inc. and United Therapeutics Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
RMD is the larger company ($27.0B vs $23.0B). On the fundamentals, UTHR grows revenue faster (16.5% vs 11.7%); UTHR earns a higher net margin (41.9% vs 27.2%); RMD has the stronger return on equity (23.5% vs 18.8%). Full numbers below — the stronger figure on each row is in green.
| ResMed Inc. (RMD) | United Therapeutics Corporation (UTHR) | |
|---|---|---|
| Market cap | $27.0B | $23.0B |
| Revenue (latest FY) | $5.15B | $3.18B |
| Net income (latest FY) | $1.40B | $1.33B |
| Revenue growth (5y CAGR) | 11.7% | 16.5% |
| Net margin | 27.2% | 41.9% |
| Return on equity | 23.5% | 18.8% |
| P/E ratio | 17.9 | 20.0 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full RMD vs UTHR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open RMD's full financials → Open UTHR's full financials →More comparisons
Frequently asked questions
Which is bigger, RMD or UTHR?
ResMed Inc. is larger by market capitalization — $27.0B versus $23.0B.
Which grows faster, RMD or UTHR?
Over the last five fiscal years, United Therapeutics Corporation grew revenue faster — 16.5%/yr versus 11.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.